122 related articles for article (PubMed ID: 9689420)
1. Single and multiple dose pharmacokinetic studies of oral sustained release and non-sustained release formulations of isosorbide-5-mononitrate in healthy volunteers.
Zhang Q; Huang X; Ji P; Fu L; Yan B; Wei S
Arzneimittelforschung; 1998 Jun; 48(6):641-5. PubMed ID: 9689420
[TBL] [Abstract][Full Text] [Related]
2. [Multiple dose pharmacokinetic and bioavailability studies of oral sustained release and conventional formulations of isosorbide-5-mononitrate in healthy volunteers].
Zhang Q; Huang X; Ji P; Fu L; Yan B; Wei S
Yao Xue Xue Bao; 1998 May; 33(5):373-8. PubMed ID: 12017006
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the bioequivalence and pharmacokinetics of two tablet formulations of isosorbide-5-mononitrate after single oral administration in healthy volunteers.
Niopas I; Daftsios AC; Nikolaidis N
Arzneimittelforschung; 2002; 52(3):182-6. PubMed ID: 11963645
[TBL] [Abstract][Full Text] [Related]
4. Sex-related differences in the pharmacokinetics of isosorbide-5-mononitrate (60 mg) after repeated oral administration of two different original prolonged release formulations.
Vree TB; Dammers E; Valducci R
Int J Clin Pharmacol Ther; 2004 Aug; 42(8):463-72. PubMed ID: 15366327
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of isosorbide mononitrate in a new sustained release oral form in comparison with a conventional formulation.
Gandini R; Cunietti E; Assereto R; Castoldi D; Tofanetti O; Baggio E
Arzneimittelforschung; 1987 Jul; 37(7):836-9. PubMed ID: 3675680
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetic profile and bioavailability of a new pharmaceutical formulation of isosorbide-5-mononitrate sustained-release formulation].
Skutta T; Böttcher B; Brandt L
Arzneimittelforschung; 1989 Apr; 39(4):507-11. PubMed ID: 2751738
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation.
Kosoglou T; Patrick JE; Cohen A; Radwanski E; Christopher D; Affrime MB
Clin Ther; 1995; 17(2):241-51. PubMed ID: 7614524
[TBL] [Abstract][Full Text] [Related]
8. Relative bioavailability of two isosorbide dinitrate sublingual tablet formulations administered as single doses in healthy subjects.
Niopas I; Daftsios AC; Nikolaidis N
Int J Clin Pharmacol Ther; 2001 May; 39(5):224-8. PubMed ID: 11380069
[TBL] [Abstract][Full Text] [Related]
9. Influence of diet on the single-dose pharmacokinetics of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate.
Sata H; Inoue K; Nii T; Kuroda T
Biol Pharm Bull; 1997 Oct; 20(10):1111-5. PubMed ID: 9353575
[TBL] [Abstract][Full Text] [Related]
10. [Bioavailability and bioequivalence of organic nitrates. Isosorbide dinitrate--a study of sustained-release preparations].
Scheidel B; Blume H; Stenzhorn G; Siewert M; Babej-Dölle RM
Arzneimittelforschung; 1991 Mar; 41(3):212-8. PubMed ID: 1867657
[TBL] [Abstract][Full Text] [Related]
11. [Bioavailability of sustained-release and nonsustained-release isosorbide-5-mononitrate].
Muck B; Bonn R; Rietbrock N
Arzneimittelforschung; 1989 Oct; 39(10):1274-6. PubMed ID: 2610720
[TBL] [Abstract][Full Text] [Related]
12. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the pharmacokinetics and absolute bioavailability of three isosorbide-5-mononitrate preparations in healthy volunteers.
Hutt V; Bonn R; Fritschi E; Jaeger H
Arzneimittelforschung; 1995 Feb; 45(2):142-5. PubMed ID: 7710435
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of sustained-release capsule of 5-isosorbide mononitrate in 20 healthy Chinese young men.
Luo WX; Zhang YD; Shen JP; Ding Y; Huang DK; Luo JP; Qiu J; Jiang ZH; Peng JH; Sheng LS
Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):951-6. PubMed ID: 11270999
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of bioavailability and pharmacokinetics of two isosorbide-5-mononitrate preparations in healthy volunteers.
Hutt V; Theodor R; Pabst G; Bonn R; Fritschi E; Jaeger H
J Clin Pharmacol; 1992 Jun; 32(6):553-7. PubMed ID: 1634643
[TBL] [Abstract][Full Text] [Related]
16. A sustained release formulation of isosorbide-5-mononitrate with a rapid onset of action.
Arthur RM; Mehmel H
Int J Clin Pract; 1999; 53(3):205-12. PubMed ID: 10665134
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic properties of isosorbide-5-mononitrate under fasting and fed conditions in healthy male subjects.
Jin C; Jeon JY; Im YJ; Jeong JA; Kim Y; Chae SW; Bentz J; Kumke T; Kim MG
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):97-106. PubMed ID: 25492848
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the initial hemodynamic effects of immediate-release versus sustained-release isosorbide-5-mononitrate following single oral doses.
Trenk D; Hinder M; Stengele E; Bonn R; Jähnchen E
J Clin Pharmacol; 2000 Feb; 40(2):168-76. PubMed ID: 10664923
[TBL] [Abstract][Full Text] [Related]
19. Single- and multiple-dose pharmacokinetic comparison of a sustained-release tablet and conventional tablets of naproxen in healthy volunteers.
Zhou D; Zhang Q; Lu W; Xia Q; Wei S
J Clin Pharmacol; 1998 Jul; 38(7):625-9. PubMed ID: 9702847
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of three organic nitrates in Chinese healthy male volunteers.
Chen J; Jiang XG; Cai L; Lu W; Gao KP; Shi ZQ; Zhang QZ
Arzneimittelforschung; 2004; 54(4):203-6. PubMed ID: 15146932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]